cancer R&D always very difficult but this stock looks cheap relative to breadth of potential and management quality. A few indications of progress and a raised profile could see the stock double very easily IMO. But not strongly promoted and the risk money back into the little miners.
cancer R&D always very difficult but this stock looks cheap...
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.6¢ | $14.17K | 2.087M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 132483 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 1945092 | 5 |
View Market Depth
| Last trade - 15.48pm 29/07/2024 (20 minute delay) ? |
| PAB (ASX) Chart |